Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Nucleic-acids-encoding-calcitonin-receptor-and-uses-thereof

 Oligonucleotide phosphate esters
OF THE PREFERRED EMBODIMENTS The present invention provides oligonucleotide analogs characterized ...


 Liposomes containing oligonucleotides
What we claim is: 1. A composition comprising cationic liposomes which consist essentially of ...


 Protonated/acidified nucleic acids and methods of use
OF THE PREFERRED EMBODIMENTS It is to be understood that this invention is not limited to the ...


 Oligonucleotide derivatives
What is claimed is: 1. A compound which is selected from the group consisting of the base ...


 Crystal forms of azithromycin
The present invention relates to crystal forms of azithromycin. As used herein, the term "crystal ...


 Method for delivering melanin to hair follicles
It has now been discovered that liposomes can selectively target the hair follicle with potentially ...


 Human G-protein coupled receptor
What is claimed is: 1. An isolated polynucleotide comprising a nucleotide sequence chosen from: a) ...


 Use of a polysaccharide excreted by the Vibrio diabolicus species in bone repair
The invention claimed is: 1. A bone reconstruction biomaterial, comprising a polysaccharide ...


 Composition for treatment of and method of monitoring hepatitis C virus using interferon-TAU
OF THE INVENTION I. Definitions Hepatitis C virus or HCV refers to the viral species of which ...


 Anti-viral guanosine-rich oligonucleotides
In one embodiment of the present invention, there is provided a method of treating a ...


 Nucleic acids encoding calcitonin receptor and uses thereof

Details
Inventors: Goldring, Steven R.; Gorn, Alan H.; Lin, Herb Y.;
Assignee: The General Hospital Corporation (Boston, MA)
Primary Examiner: Parr; Margaret
Assistant Examiner: Sisson; Bradley L.
Attorney, Agent or Firm: Fish & Richardson

Recombinant DNA which encodes a calcitonin receptor polypeptide, vectors and hosts containing the recombinant DNA, and methods for expressing a calcitonin receptor polypeptide from the recombinant DNA are described.

DETAILED DESCRIPTION The Drawings The drawings are first described.
FIGS.
1A and 1B are a composite of graphs depicting binding of porcine calcitonin to cells.
FIG.
1A) Porcine calcitonin binding to LLC-PK.
sub.
1 cells; FIG.
1B) Porcine calcitonin binding to COS cells transfected with cDNA encoding porcine CTR.
Insets show Scatchard analysis of the binding data.
FIG.
2A is a histogram of the cAMP response in FIG.
2A) porcine calcitonin receptor-transfected COS cells and FIG.
2B) is a histogram of the cAMP response in COS cells mock-transfected with .
beta.
-galactosidase.
SCT=salmon calcitonin and ISO=isoproterenol.
FIG.
3 is the amino acid sequence of porcine CTR (SEQ ID NO:1) aligned with the PTH-PTHrP receptor.
The alignment was generated with UWGCG program GAP (Devereux et al.
, 1984, Nucl.
Acids Res.
12:387).
Shaded boxes represent identity or similarity.
The bars above the sequence represent the transmembrane domains.
Symbol # indicates N-linked glycosylation sites and + indicates conserved cysteines.
FIG.
4A (low power) and FIG.
4B (high power) are emulsion autoradiographs of BIN-67 cells in culture following incubation with [.
sup.
125 I]-salmon calcitonin.
FIG.
5A is a graph of binding of salmon calcitonin to BIN-67 cells, and FIG.
5B is a graph of binding of salmon calcitonin to COS cells transfected with the human CTR cDNA.
Insets show Scatchard analysis of binding data.
FIGS.
6A, 6B, and 6C are a composite of graphs of binding and cAMP dose response of human and salmon calcitonins in BIN-67 cells.
FIG.
6A) cAMP dose response curves to salmon and human calcitonin; FIG.
6B) Competition dissociation binding curves for [.
sup.
125 I]-human calcitonin competed with unlabeled human calcitonin; FIG.
6C) Human calcitonin binding to BIN-67 cells.
Maximal binding was 1.
92.
times.
10.
sup.
4 cpm per sample; the inset shows a Scatchard analysis of binding data.
FIGS.
7A, 7B, and 7C are histograms representing the cAMP response in BIN-67 cells and in transfected COS cells.
FIG.
7A) Mock (.
beta.
-galactosidase) transfected COS cells; FIG



Related patents
  Tricyclic macrolide antibacterial compounds
OF THE INVENTION Compounds of this invention, also referred to as "the compounds," comprise both fixed and variable moieties, which variable moieties are identified by ...
  Gene encoding MNR2 and uses thereof
OF THE INVENTION The following standard abbreviations are used throughout the specification to indicate specific nucleotides: C=cytosine A=adenosine T=thymidine G=...
  Polyene microlide pre-liposomal powders
OF THE PREFERRED EMBODIMENT A stable powder suitable for the direct preparation of liposome-incorporated antifungal polyene macrolides may be made by a process of the ...
  Process for stabilizing liposomes
We claim: 1. A process for stabilizing liposomes comprising: a) first forming liposomes by hydrating a lipid film with an aqueous solution containing less than 10 mM of ...
  cDNA encoding human phospholipase A.sub.2 polypeptide
OF THE INVENTION The present invention provides a novel intracellular human phospholipase A.sub.2 that employs a catalytic strategy distinct from that utilized by ...
  DNA encoding Bcl-2-associated proteins
The present invention relates to a nucleic acid molecule encoding a protein or a fragment thereof that associates with Bcl-2 or a Bcl-2-related protein. The invention ...
  Hybridoma-producing NSO myeloma cell line
This invention is directed to NSO.sup.bcl-2 myeloma cells and to methods of producing said cells. The NSO.sup.bcl-2 myeloma cells of the invention have high fusion ...
  Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells
OF THE PREFERRED EMBODIMENTS The present invention provides an improved method for the encapsulation of high molecular weight nucleic acids in liposomes, wherein a ...
  Bax inhibitor proteins
The present invention provides substantially purified nucleic acid molecules encoding Bax inhibitor proteins, including Bax inhibitor protein-1 (BI-1) and Bax inhibitor ...
  Phosphonomonoester nucleic acids, process for their preparation, and their use
What is claimed is: 1. A compound of formula I ##STR37## in which n is a number from zero to 100; A independently of one another is a single bond, a methylene group or a ...

0.014

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved